Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 63Gynecologic 6Gastrointestinal 5Genitourinary 3Dermatologic 3Thoracic 2Sarcoma 2Other solid neoplasm 2Endocrine 2Breast 2Plasma cell 1Other hematologic neoplasm 1Other 1NET 1CNS 1

Conditions

Obesity 32Neoplasms 11Breast Neoplasms 9Overweight 8Dyspnea 7Sexual Dysfunction, Physiological 6Mucositis 5Endometrial Neoplasms 5Pediatric Obesity 4Motor Activity 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Diabetes Mellitus, Type 2 3Weight Loss 2Uterine Cervical Neoplasms 2Syndrome 2Stomatitis 2Pulmonary Disease, Chronic Obstructive 2Pain 2Obesity-Related Malignant Neoplasm 2Leukemia 2Insulin Resistance 2Infertility 2Fatigue 2Endometrial Hyperplasia 2Cough 2Constipation 2Colorectal Neoplasms 2Vomiting 1Ulcer 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Other × 90 days × Clear all
NCT04251949 2026-03-18

MuciLight

Centre Oscar Lambret

Phase 2 Completed
28 enrolled
Head & NeckOther

Mouth Neoplasms, Oropharyngeal Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡